Sector Gamma ASA
Latest statistics and disclosures from Sector Gamma As's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MDT, PFE, GILD, BIIB, INCY, and represent 36.34% of Sector Gamma As's stock portfolio.
- Added to shares of these 10 stocks: PFE (+$32M), CVS (+$17M), MDT (+$8.8M), BIO (+$7.6M), ILMN (+$5.7M), ALKS (+$5.5M), BAX (+$5.2M), ABT, Qiagen Nv, THC.
- Started 6 new stock positions in ILMN, PFE, BIO, CVS, ALKS, ABT.
- Reduced shares in these 10 stocks: GILD (-$20M), BDX (-$19M), BMY (-$15M), CAH (-$10M), CTLT (-$9.4M), ELV (-$6.3M), ALNY, LH, KVUE, AMED.
- Sold out of its positions in AMED, BDX, CTLT, KVUE.
- Sector Gamma As was a net seller of stock by $-4.6M.
- Sector Gamma As has $412M in assets under management (AUM), dropping by 5.33%.
- Central Index Key (CIK): 0001475373
Tip: Access up to 7 years of quarterly data
Positions held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Sector Gamma As
Sector Gamma As holds 30 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Medtronic SHS (MDT) | 8.7 | $36M | +32% | 435k | 82.38 |
|
Pfizer (PFE) | 7.6 | $32M | NEW | 1.1M | 28.79 |
|
Gilead Sciences (GILD) | 7.5 | $31M | -38% | 382k | 81.01 |
|
Biogen Idec (BIIB) | 6.4 | $27M | 102k | 258.77 |
|
|
Incyte Corporation (INCY) | 6.1 | $25M | -7% | 399k | 62.79 |
|
Bristol Myers Squibb (BMY) | 4.7 | $19M | -44% | 375k | 51.31 |
|
Ge Healthcare Technologies I Common Stock (GEHC) | 4.6 | $19M | +7% | 248k | 77.32 |
|
CVS Caremark Corporation (CVS) | 4.2 | $17M | NEW | 219k | 78.96 |
|
Zimmer Holdings (ZBH) | 4.2 | $17M | -11% | 141k | 121.70 |
|
Cardinal Health (CAH) | 4.0 | $17M | -37% | 164k | 100.80 |
|
Centene Corporation (CNC) | 3.9 | $16M | -3% | 216k | 74.21 |
|
Tenet Healthcare Corp Com New (THC) | 3.5 | $15M | +22% | 193k | 75.57 |
|
Edwards Lifesciences (EW) | 3.5 | $14M | -11% | 188k | 76.25 |
|
Anthem (ELV) | 3.2 | $13M | -32% | 28k | 471.56 |
|
Baxter International (BAX) | 3.1 | $13M | +69% | 328k | 38.66 |
|
Globus Med Cl A (GMED) | 3.0 | $13M | +5% | 234k | 53.29 |
|
Laboratory Corp Amer Hldgs Com New (LH) | 2.8 | $12M | -21% | 51k | 227.29 |
|
Bruker Corporation (BRKR) | 2.3 | $9.4M | +23% | 127k | 73.48 |
|
BioMarin Pharmaceutical (BMRN) | 2.0 | $8.3M | -10% | 86k | 96.42 |
|
Qiagen Nv Shs New | 2.0 | $8.3M | +89% | 191k | 43.43 |
|
Bio Rad Labs Cl A (BIO) | 1.8 | $7.6M | NEW | 24k | 322.89 |
|
Ionis Pharmaceuticals (IONS) | 1.8 | $7.3M | -12% | 145k | 50.59 |
|
Alnylam Pharmaceuticals (ALNY) | 1.5 | $6.1M | -39% | 32k | 191.41 |
|
ACADIA Pharmaceuticals (ACAD) | 1.4 | $5.9M | +4% | 188k | 31.31 |
|
Illumina (ILMN) | 1.4 | $5.7M | NEW | 41k | 139.24 |
|
Alkermes SHS (ALKS) | 1.3 | $5.5M | NEW | 200k | 27.74 |
|
Ultragenyx Pharmaceutical (RARE) | 1.2 | $4.9M | -11% | 103k | 47.82 |
|
Abbott Laboratories (ABT) | 1.1 | $4.4M | NEW | 40k | 110.07 |
|
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.8 | $3.2M | +2% | 52k | 62.00 |
|
Vir Biotechnology (VIR) | 0.4 | $1.5M | 149k | 10.06 |
|
Past Filings by Sector Gamma As
SEC 13F filings are viewable for Sector Gamma As going back to 2010
- Sector Gamma As 2023 Q4 filed Feb. 5, 2024
- Sector Gamma As 2023 Q3 filed Nov. 6, 2023
- Sector Gamma As 2023 Q2 filed Aug. 9, 2023
- Sector Gamma As 2023 Q1 filed May 12, 2023
- Sector Gamma As 2022 Q4 restated filed Feb. 8, 2023
- Sector Gamma As 2022 Q4 filed Feb. 7, 2023
- Sector Gamma As 2022 Q3 filed Nov. 9, 2022
- Sector Gamma As 2022 Q2 filed Aug. 5, 2022
- Sector Gamma As 2022 Q1 filed May 6, 2022
- Sector Gamma As 2021 Q4 filed Feb. 8, 2022
- Sector Gamma As 2021 Q3 filed Oct. 29, 2021
- Sector Gamma As 2021 Q2 filed Aug. 4, 2021
- Sector Gamma As 2021 Q1 filed May 10, 2021
- Sector Gamma As 2020 Q4 filed Feb. 10, 2021
- Sector Gamma As 2020 Q3 filed Nov. 9, 2020
- Sector Gamma As 2020 Q2 filed Aug. 7, 2020